Literature DB >> 17630775

Ornithine decarboxylase antizyme upregulates DNA-dependent protein kinase and enhances the nonhomologous end-joining repair of DNA double-strand breaks in human oral cancer cells.

Takanori Tsuji1, Miki Katsurano, Soichiro Ibaragi, Kaori Shima, Akira Sasaki, Guo-Fu Hu.   

Abstract

Ornithine decarboxylase (ODC) antizyme targets ODC for ubiquitin-independent proteosome degradation, thereby inhibiting polyamine synthesis. It has been shown to regulate DNA methylation and has tumor suppressor activity. Increasing evidence suggested that antizyme may also have ODC-independent functions. Here, we report that antizyme plays a role in DNA double-strand break repairs. A zinc-inducible human antizyme gene expression vector was transfected into UM1 human oral squamous cancer cells that do not express endogenous antizyme. The resultant upregulated genes were screened by cDNA arrays and confirmed by quantitative real-time polymerase chain reaction. DNA-dependent protein kinase including its catalytic subunit DNA-PKcs and regulatory subunit Ku70, two key proteins of the DNA damage repair machinery, was significantly upregulated after ectopic expression of antizyme. Consistently, we found that UM1 cells are sensitive to gamma irradiation and deficient in DNA damage repairs, as shown by radio-sensitivity and Comet assays. Ectopic expression of antizyme increased radio-resistance of UM1 cells and restored their capacity of DNA damage repairs to the level of UM2 cells that have an identical genetic background but express endogenous antizyme. Plasmid end-joining assays confirmed that antizyme enhances the ability of UM1 cells to repair DNA double-strand breaks by the nonhomologous end-joining pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630775     DOI: 10.1021/bi7000328

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Knockdown of ornithine decarboxylase antizyme 1 causes loss of uptake regulation leading to increased N1, N11-bis(ethyl)norspermine (BENSpm) accumulation and toxicity in NCI H157 lung cancer cells.

Authors:  Alison V Fraser; Andrew C Goodwin; Amy Hacker-Prietz; Elizabeth Sugar; Patrick M Woster; Robert A Casero
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

2.  Ornithine decarboxylase antizyme induces hypomethylation of genome DNA and histone H3 lysine 9 dimethylation (H3K9me2) in human oral cancer cell line.

Authors:  Daisuke Yamamoto; Kaori Shima; Kou Matsuo; Takashi Nishioka; Chang Yan Chen; Guo-Fu Hu; Akira Sasaki; Takanori Tsuji
Journal:  PLoS One       Date:  2010-09-03       Impact factor: 3.240

Review 3.  Antizyme and antizyme inhibitor, a regulatory tango.

Authors:  Chaim Kahana
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

4.  Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients.

Authors:  Yi-Shing Lisa Cheng; Lee Jordan; Terry Rees; Huey-Shys Chen; Lance Oxford; Ole Brinkmann; David Wong
Journal:  Clin Oral Investig       Date:  2013-07-28       Impact factor: 3.573

5.  OAZ1 knockdown enhances viability and inhibits ER and LHR transcriptions of granulosa cells in geese.

Authors:  Bo Kang; Dongmei Jiang; Rong Ma; Hui He; Zhixin Yi; Ziyu Chen
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.